Taking aim at targets.

population: the European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study. Int J Epidemiol 2004; 33: 189–198 23. Yuyun MF, Khaw KT, Luben R et al. Microalbuminuria and stroke in a British population: the European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study. J Intern Med 2004; 255: 247–256 24. Harwell TS, Nelson RG, Little RR et al. Testing for microalbuminuria in 2002: barriers to implementing current guidelines. Am J Kidney Dis 2003; 42: 245–248 25. Carel RS, Silverberg DS, Kaminsky R et al. Routine urinalysis (dipstick) findings in mass screening of healthy adults. Clin Chem 1987; 33: 2106–2108 26. de Jong PE, Curhan GC. Screening, monitoring, and treatment of albuminuria: public health perspectives. J Am Soc Nephrol 2006; 17: 2120–2126 27. Parikh CR, Fischer MJ, Estacio R et al. Rapid microalbuminuria screening in type 2 diabetes mellitus: simplified approach with Micral test strips and specific gravity. Nephrol Dial Transplant 2004; 19: 1881–1885 28. Ludimu Tugirimana P, Delanghe J. Development of an affordable dye-stained microalbuminuria screening test. Nephrol Dial Transplant 2009; 24: 1485–1490 29. Bang H, Vupputuri S, Shoham DA et al. SCreening for Occult REnal Disease (SCORED): a simple prediction model for chronic kidney disease. Arch Intern Med 2007; 167: 374–381 30. Ruggenenti P, Pagano E, Tammuzzo L et al. Ramipril prolongs life and is cost effective in chronic proteinuric nephropathies. Kidney Int 2001; 59: 286–294 31. Palmer AJ, Annemans L, Roze S et al. An economic evaluation of the Irbesartan in Diabetic Nephropathy Trial (IDNT) in a UK setting. J Hum Hypertens 2004; 18: 733–738 32. Dirks JH, Robinson SW, Alderman M et al. Meeting report on the Bellagio Conference ‘prevention of vascular diseases in the emerging world: an approach to global health equity’. Kidney Int 2006; 70: 1397–1402 33. International Society of Nephrology. Program for detection and management of chronic kidney disease, hypertension, diabetes, and cardiovascular disease in developing countries (KHDC). http: //www. isn-online.org/isn/education/guidelines/isn/full/ed_051027_1.html